Tempus Ex Machina completed the acquisition of Biocore.

Tempus Ex Machina, a sports technology startup, completed the acquisition of Biocore, a biomechanical engineering, with its data science teams developing analytics platforms that allow teams, federations and athletes to understand and prevent injuries. Financial terms were not disclosed. “We have been utilising Tempus Ex’s proprietary FusionFeed technology for quite some time and it has revolutionised our technology and processes,” Dr Jeff Crandall, Biocore Chief Executive.